Incidence, Mortality, and Survival Trends of Liver Cancer in the Canton of Zurich, Switzerland, Between 1980 and 2022.
- 1Cancer Registry of the Canton Zurich, Zug, Schaffhausen and Schwyz, University Hospital Zurich, Zurich, Switzerland.
- 2Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, Zurich, Switzerland.
Abstract
Background
The global burden of liver cancer has been increasing over recent decades, whereas the incidence in Switzerland has remained relatively stable. This study assessed long-term trends in incidence, mortality, and 1- and 5-year relative survival of primary liver cancer in the Swiss canton of Zurich from 1980 to 2022, stratified by sex and age.Methods
This population-based retrospective analysis included all primary liver cancer cases diagnosed in the canton of Zurich and registered in the Cancer Registry of the cantons of Zurich, Zug, Schaffhausen and Schwyz between 1980 and 2022. Mortality data were obtained from the Federal Statistical Office. Cases were classified according to ICD-O-3 topography and morphology and, from 2003 onward, TNM stage. Age-standardised incidence and mortality rates were calculated using the 1976 European standard population. Temporal trends were analysed using Joinpoint regression and reported as Average Annual Percentage Changes (AAPCs) with 95% confidence intervals (CIs). Relative survival was estimated using the Ederer II method and standardised according to international standards.Results
Among 3866 incident cases, 71.3% were hepatocellular carcinomas and 70.7% occurred in men. Overall age-standardised incidence remained stable in both men (AAPC -0.1%, 95% CI -0.6 to 0.3%) and women (-0.2%, -0.9% to 0.4%). However, incidence increased significantly among individuals younger than 65 years, particularly in women (AAPC 2.3%, 1.3%-3.3%) and men (1.2%, 0.6%-1.9%). Mortality remained broadly stable in men and increased modestly in women. One- and five-year relative survival improved substantially, from 13.8% and 3.5% in 1980-1999 to 53.9% and 25.8% in 2016-2022, respectively. Improvements were greater in men than women.Conclusion
These findings reflect major advances in liver cancer diagnosis and treatment over the past four decades. Continued prevention, targeted screening of high-risk groups, and epidemiological monitoring remain important.
Related
- Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980–2023) with focus on younger women (0–49 years old)
- Sex- and Region-Specific Incidence and Mortality Trends in Laryngeal and Oropharyngeal Cancer: A 95,000-Case Population-Based Registry Analysis from Poland, 1999–2023
- Population-based trends in cervical cancer incidence and net survival in Cyprus (2004-2017)
- Cross-National Comparison of Divergence Between Long-term Incidence and Mortality Trends in Lip and Oral Cavity Cancer and Associated Health-System Factors: A Population-Based Paired-Trend Study
- Long-term trends in cancer incidence and mortality in Italy: cohort patterns and young-age risks
BibTeX
@article{zuber2026incidence,
title = {{Incidence, Mortality, and Survival Trends of Liver Cancer in the Canton of Zurich, Switzerland, Between 1980 and 2022.}},
author = {Nina Zuber and Flurina Suter and Miriam Wanner and Dimitri Korol and Sabine Rohrmann},
journal = {Cancer medicine},
year = {2026},
month = oct,
doi = {10.1002/cam4.72393},
url = {https://europepmc.org/article/MED/42902936},
note = {CC BY},
}
RIS
TY - JOUR
TI - Incidence, Mortality, and Survival Trends of Liver Cancer in the Canton of Zurich, Switzerland, Between 1980 and 2022.
AU - Nina Zuber
AU - Flurina Suter
AU - Miriam Wanner
AU - Dimitri Korol
AU - Sabine Rohrmann
PY - 2026
DA - 2026/10/01
JO - Cancer medicine
DO - 10.1002/cam4.72393
UR - https://europepmc.org/article/MED/42902936
AB - Background The global burden of liver cancer has been increasing over recent decades, whereas the incidence in Switzerland has remained relatively stable. This study assessed long-term trends in incidence, mortality, and 1- and 5-year relative survival of primary liver cancer in the Swiss canton of Zurich from 1980 to 2022, stratified by sex and age.Methods This population-based retrospective analysis included all primary liver cancer cases diagnosed in the canton of Zurich and registered in the Cancer Registry of the cantons of Zurich, Zug, Schaffhausen and Schwyz between 1980 and 2022. Mortality data were obtained from the Federal Statistical Office. Cases were classified according to ICD-O-3 topography and morphology and, from 2003 onward, TNM stage. Age-standardised incidence and mortality rates were calculated using the 1976 European standard population. Temporal trends were analysed using Joinpoint regression and reported as Average Annual Percentage Changes (AAPCs) with 95% confidence intervals (CIs). Relative survival was estimated using the Ederer II method and standardised according to international standards.Results Among 3866 incident cases, 71.3% were hepatocellular carcinomas and 70.7% occurred in men. Overall age-standardised incidence remained stable in both men (AAPC -0.1%, 95% CI -0.6 to 0.3%) and women (-0.2%, -0.9% to 0.4%). However, incidence increased significantly among individuals younger than 65 years, particularly in women (AAPC 2.3%, 1.3%-3.3%) and men (1.2%, 0.6%-1.9%). Mortality remained broadly stable in men and increased modestly in women. One- and five-year relative survival improved substantially, from 13.8% and 3.5% in 1980-1999 to 53.9% and 25.8% in 2016-2022, respectively. Improvements were greater in men than women.Conclusion These findings reflect major advances in liver cancer diagnosis and treatment over the past four decades. Continued prevention, targeted screening of high-risk groups, and epidemiological monitoring remain important.
SN - 2045-7634
ER -